ProfileGDS5678 / 1420623_x_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.435599
GSM967853U87-EV human glioblastoma xenograft - Control 211.504799
GSM967854U87-EV human glioblastoma xenograft - Control 311.576299
GSM967855U87-EV human glioblastoma xenograft - Control 411.92899
GSM967856U87-EV human glioblastoma xenograft - Control 511.541199
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.304399
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.039399
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.539199
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.614199
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.551999
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.494899
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.555699
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.710999
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.619299